JP2013517758A5 - - Google Patents

Download PDF

Info

Publication number
JP2013517758A5
JP2013517758A5 JP2012513400A JP2012513400A JP2013517758A5 JP 2013517758 A5 JP2013517758 A5 JP 2013517758A5 JP 2012513400 A JP2012513400 A JP 2012513400A JP 2012513400 A JP2012513400 A JP 2012513400A JP 2013517758 A5 JP2013517758 A5 JP 2013517758A5
Authority
JP
Japan
Prior art keywords
myc
seq
variant
human
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012513400A
Other languages
English (en)
Japanese (ja)
Other versions
JP5827220B2 (ja
JP2013517758A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2011/051685 external-priority patent/WO2011090221A1/en
Publication of JP2013517758A publication Critical patent/JP2013517758A/ja
Publication of JP2013517758A5 publication Critical patent/JP2013517758A5/ja
Application granted granted Critical
Publication of JP5827220B2 publication Critical patent/JP5827220B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012513400A 2010-01-22 2011-01-21 人工多能性幹細胞の樹立効率改善方法 Active JP5827220B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28232010P 2010-01-22 2010-01-22
US61/282,320 2010-01-22
PCT/JP2011/051685 WO2011090221A1 (en) 2010-01-22 2011-01-21 Method for improving induced pluripotent stem cell generation efficiency

Publications (3)

Publication Number Publication Date
JP2013517758A JP2013517758A (ja) 2013-05-20
JP2013517758A5 true JP2013517758A5 (cg-RX-API-DMAC7.html) 2014-03-06
JP5827220B2 JP5827220B2 (ja) 2015-12-02

Family

ID=44307020

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012513400A Active JP5827220B2 (ja) 2010-01-22 2011-01-21 人工多能性幹細胞の樹立効率改善方法

Country Status (4)

Country Link
US (1) US9005967B2 (cg-RX-API-DMAC7.html)
EP (1) EP2526189B1 (cg-RX-API-DMAC7.html)
JP (1) JP5827220B2 (cg-RX-API-DMAC7.html)
WO (1) WO2011090221A1 (cg-RX-API-DMAC7.html)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140063501A (ko) 2010-12-22 2014-05-27 페이트 세러퓨틱스, 인코포레이티드 단세포 분류 및 iPSC의 증강된 재프로그래밍을 위한 세포 배양 플랫폼
AU2014212230B2 (en) 2013-02-01 2019-07-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Method for generating retinal pigment epithelium (RPE) cells from induced pluripotent stem cells (iPSCs)
EP2954046B1 (en) 2013-02-06 2025-10-15 University Of Rochester Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders
ES2966757T3 (es) * 2014-03-04 2024-04-24 Fate Therapeutics Inc Métodos de reprogramación mejorados y plataformas de cultivo celular
US9724432B2 (en) 2015-04-30 2017-08-08 University Of Rochester Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
AU2016321170B2 (en) 2015-09-08 2022-09-01 Fujifilm Cellular Dynamics Method for reproducible differentiation of clinical-grade retinal pigment epithelium cells
EP3347457B1 (en) 2015-09-08 2021-10-27 FUJIFILM Cellular Dynamics, Inc. Macs-based purification of stem cell-derived retinal pigment epithelium
SG10202111851YA (en) 2015-10-16 2021-12-30 Fate Therapeutics Inc Platform for the Induction & Maintenance of Ground State Pluripotency
US10947502B2 (en) 2015-10-20 2021-03-16 FUJIFILM Cellular Dynamics, Inc. Methods for directed differentiation of pluripotent stem cells to immune cells
CA3029582A1 (en) 2016-07-01 2018-01-04 Research Development Foundation Elimination of proliferating cells from stem cell-derived grafts
US11866733B2 (en) 2016-08-01 2024-01-09 University of Pittsburgh—of the Commonwealth System of Higher Education Human induced pluripotent stem cells for high efficiency genetic engineering
JP7248571B2 (ja) 2016-10-05 2023-03-29 フジフィルム セルラー ダイナミクス,インコーポレイテッド MeCP2が破壊された誘導多能性幹細胞からの成熟系列の生成
US11458225B2 (en) 2016-11-09 2022-10-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 3D vascularized human ocular tissue for cell therapy and drug discovery
US11530388B2 (en) 2017-02-14 2022-12-20 University of Pittsburgh—of the Commonwealth System of Higher Education Methods of engineering human induced pluripotent stem cells to produce liver tissue
EP4083063A3 (en) 2017-04-18 2023-01-04 FUJIFILM Cellular Dynamics, Inc. Antigen-specific immune effector cells
EP3621434A4 (en) 2017-05-10 2021-03-31 University of Rochester METHOD OF TREATMENT OF NEUROPSYCHIATRIC DISORDERS
EP3781675A1 (en) 2018-04-20 2021-02-24 FUJIFILM Cellular Dynamics, Inc. Method for differentiation of ocular cells and use thereof
EP3806861A1 (en) 2018-06-18 2021-04-21 University of Rochester Methods of treating schizophrenia and other neuropsychiatric disorders
CA3103675A1 (en) 2018-06-21 2019-12-26 University Of Rochester Methods of treating or inhibiting onset of huntington's disease
WO2020009714A1 (en) * 2018-07-02 2020-01-09 Lin Shi Lung In-Vitro Induction of Adult Stem Cell Expansion and Derivation
CN113226387B (zh) 2018-11-19 2024-02-23 美国政府(由卫生和人类服务部的部长所代表) 可生物降解的组织置换植入物及其用途
AU2019386140A1 (en) 2018-11-28 2021-06-24 Board Of Regents, The University Of Texas System Multiplex genome editing of immune cells to enhance functionality and resistance to suppressive environment
MX2021006393A (es) 2018-11-29 2021-10-13 Univ Texas Metodos para expansion ex vivo de celulas exterminadoras naturales y uso de las mismas.
EP3894556A1 (en) 2018-12-11 2021-10-20 University of Rochester Methods of treating schizophrenia and other neuropsychiatric disorders
WO2020167822A2 (en) 2019-02-13 2020-08-20 University Of Rochester Gene networks that mediate remyelination of the human brain
AU2021235185A1 (en) 2020-03-09 2022-11-03 Fujifilm Corporation Markers specific for pluripotent stem cells, and methods of using the same
PH12022553083A1 (en) 2020-05-29 2024-03-25 Fujifilm Cellular Dynamics Inc Bilayer of retinal pigmented epithelium and photoreceptors and use thereof
WO2021243256A1 (en) 2020-05-29 2021-12-02 FUJIFILM Cellular Dynamics, Inc. Retinal pigmented epithelium and photoreceptor dual cell aggregates and methods of use thereof
WO2022104109A1 (en) 2020-11-13 2022-05-19 Catamaran Bio, Inc. Genetically modified natural killer cells and methods of use thereof
JP2023550453A (ja) 2020-11-18 2023-12-01 富士フイルム株式会社 セクレトーム含有組成物の生成、並びにその使用及び分析方法
KR20230113768A (ko) 2020-11-24 2023-08-01 모나쉬 유니버시티 유도 줄기 세포
JP2023550181A (ja) 2020-11-24 2023-11-30 モナシュ ユニバーシティ 方法及び細胞構造体
US20220162288A1 (en) 2020-11-25 2022-05-26 Catamaran Bio, Inc. Cellular therapeutics engineered with signal modulators and methods of use thereof
CA3214490A1 (en) 2021-03-25 2022-09-29 Bluerock Therapeutics Lp Methods for obtaining induced pluripotent stem cells
KR20240011831A (ko) 2021-05-26 2024-01-26 후지필름 셀룰러 다이내믹스, 인코포레이티드 만능 줄기 세포에서 유전자의 신속한 사일런싱을 방지하기 위한 방법
AU2022280062A1 (en) 2021-05-28 2023-11-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods to generate macular, central and peripheral retinal pigment epithelial cells
CA3220433A1 (en) 2021-05-28 2022-12-01 Arvydas Maminishkis Biodegradable tissue scaffold with secondary matrix to host weakly adherent cells
KR20240056604A (ko) 2021-09-13 2024-04-30 후지필름 셀룰러 다이내믹스, 인코포레이티드 수임 심장 전구세포의 제조 방법
WO2023069843A1 (en) 2021-10-20 2023-04-27 University Of Rochester Humanized chimeras for the prospective assessment of cell addition and replacement therapies
AU2022368907A1 (en) 2021-10-20 2024-05-02 University Of Copenhagen Rejuvenation treatment of age-related white matter loss
JP2024539140A (ja) 2021-10-20 2024-10-28 ユニヴァーシティ オヴ ロチェスター グリア前駆細胞を若返らせるための方法及び若返ったグリア前駆細胞それ自体
JP2024542015A (ja) 2021-11-02 2024-11-13 ユニバーシティ オブ ロチェスター 脳内でのtcf7l2媒介性髄鞘再生
WO2023150557A1 (en) 2022-02-01 2023-08-10 University Of Rochester Methods of generating a population of neurons from human glial progenitor cells and genetic constructs for carrying out such methods
WO2023172514A1 (en) 2022-03-07 2023-09-14 Catamaran Bio, Inc. Engineered immune cell therapeutics targeted to her2 and methods of use thereof
EP4518876A1 (en) 2022-05-05 2025-03-12 University of Rochester Dual macroglial-microglial approach towards therapeutic cell replacement in neurodegenerative and neuropsychiatric disease
WO2024006911A1 (en) 2022-06-29 2024-01-04 FUJIFILM Holdings America Corporation Ipsc-derived astrocytes and methods of use thereof
JP2025532957A (ja) 2022-09-30 2025-10-03 フジフィルム セルラー ダイナミクス,インコーポレイテッド 心臓線維芽細胞の作製方法
EP4658294A2 (en) 2023-02-02 2025-12-10 University of Rochester Competitive replacement of glial cells
WO2024192329A1 (en) 2023-03-16 2024-09-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for producing stable human chondroctyes and their use for promoting cartillage growth and repair
WO2025245202A1 (en) 2024-05-21 2025-11-27 FUJIFILM Cellular Dynamics, Inc. Particle counting and biomass measurements of aggregated cell compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937190A (en) 1987-10-15 1990-06-26 Wisconsin Alumni Research Foundation Translation enhancer
DK1084230T3 (da) 1998-06-08 2008-03-03 Osiris Therapeutics Inc Regulering af hæmatopoietisk stamcelledifferentiering ved anvendelse af humane mesenkymstamceller
CA2368948C (en) 1999-05-18 2013-12-24 Dnavec Research Inc. Envelope gene-deficient virus vector of paramyxoviridae
US6602711B1 (en) 2000-02-21 2003-08-05 Wisconsin Alumni Research Foundation Method of making embryoid bodies from primate embryonic stem cells
JP3660601B2 (ja) 2001-03-30 2005-06-15 独立行政法人科学技術振興機構 胚性幹細胞からの神経幹細胞、運動ニューロン及びgaba作動性ニューロンの製造法
JP2004121165A (ja) 2002-10-07 2004-04-22 Asahi Kasei Corp 膵幹様細胞の分化誘導方法
AU2006325975B2 (en) 2005-12-13 2011-12-08 Kyoto University Nuclear reprogramming factor
US20090227032A1 (en) 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
DK3399025T3 (da) 2007-03-23 2025-06-16 Wisconsin Alumni Res Found Omprogrammering af somatiske celler
CA2660123C (en) 2007-10-31 2017-05-09 Kyoto University Nuclear reprogramming method

Similar Documents

Publication Publication Date Title
JP2013517758A5 (cg-RX-API-DMAC7.html)
JP2013544069A5 (cg-RX-API-DMAC7.html)
JP2011529330A5 (cg-RX-API-DMAC7.html)
JP2015506673A5 (cg-RX-API-DMAC7.html)
JP2011525793A5 (cg-RX-API-DMAC7.html)
RU2018112719A (ru) Способы и препараты для трансфекции клеток
JP2013519371A5 (cg-RX-API-DMAC7.html)
JP2012527887A5 (cg-RX-API-DMAC7.html)
JP2013505701A5 (cg-RX-API-DMAC7.html)
JP2018534922A5 (cg-RX-API-DMAC7.html)
JP2013524780A5 (cg-RX-API-DMAC7.html)
JP2014240404A5 (cg-RX-API-DMAC7.html)
ATE502108T1 (de) Rsv f-protein und seine verwendung
RU2012101874A (ru) Получение индуцированных плюрипотентных стволовых клеток из пуповинной крови
BR112012004823A8 (pt) Anticorpo ou fragmento de ligação de antígeno do mesmo, uso de um anticorpo ou um fragmento de ligação de antígeno do mesmo, e composição farmacêutica
JP2012501680A5 (cg-RX-API-DMAC7.html)
WO2013059524A3 (en) Antibodies directed against influenza
WO2011100477A3 (en) Antibodies and processes for preparing the same
EP3825322C0 (en) POLYPEPTIDE COMPOUND, PHARMACEUTICAL COMPOSITION, PREPARATION METHOD AND ASSOCIATED APPLICATION
WO2011153981A3 (de) Verfahren zur herstellung einer organnachbildung, insbesondere eines funktionsmodells
JPWO2015046229A1 (ja) 多能性幹細胞の誘導効率を改善する方法
EA201400192A1 (ru) Клетка, ферментирующая пентозы
JP2016510990A5 (cg-RX-API-DMAC7.html)
JP2020520241A5 (cg-RX-API-DMAC7.html)
WO2017203370A3 (en) Cmv epitopes